-
IntroducedNov 07, 2025
-
Passed Senate
-
Passed House
-
Became Law
Florida Senate Bill
Controlled Substances; Adding 7-Hydroxymitragynine as a Schedule I controlled substance; excepting from the list of Schedule I controlled substances certain xylazine animal drug products approved by the United States Food and Drug Administration and used for certain purposes; providing criminal penalties and requiring a mandatory minimum term of imprisonment if a person sells, manufactures, or delivers or possesses with intent to sell, manufacture, or deliver xylazine; creating the offense of trafficking in xylazine; providing criminal penalties and requiring a mandatory minimum term of imprisonment and fines based on the quantity of the controlled substance involved in the offense, etc.
Last Action See all actions
Senate • Jan 21, 2026: Now in Fiscal Policy
Latest Bill Text See all bill texts
Summary
Comments on SB 432
Tweets
Whip Lists
Sponsors
Votes
Actions
- Jan 21, 2026 | Senate
- Favorable by Appropriations Committee on Criminal and Civil Justice; YEAS 8 NAYS 0
- Now in Fiscal Policy
- Jan 16, 2026 | Senate
- On Committee agenda-- Appropriations Committee on Criminal and Civil Justice, 01/21/26, 1:30 pm, 37 Senate Building
- Jan 13, 2026 | Senate
- Introduced
- Jan 12, 2026 | Senate
- Favorable by Criminal Justice; YEAS 8 NAYS 0
- Now in Appropriations Committee on Criminal and Civil Justice
- Jan 05, 2026 | Senate
- On Committee agenda-- Criminal Justice, 01/12/26, 1:30 pm, 37 Senate Building
- Dec 01, 2025 | Senate
- Referred to Criminal Justice; Appropriations Committee on Criminal and Civil Justice; Fiscal Policy
- Nov 07, 2025 | Senate
- Filed
Bill Texts
Documents
- Bill Analysis -- Criminal Justice (Pre-Meeting) (1/9/2026 1:28 PM)
- Bill Analysis -- Criminal Justice (Post-Meeting) (1/12/2026 4:09 PM)
- Bill Analysis -- Appropriations Committee on Criminal and Civil Justice (Pre-Meeting) (1/20/2026 11:25 AM)
- Bill Analysis -- Appropriations Committee on Criminal and Civil Justice (Post-Meeting) (1/21/2026 4:02 PM)

